Status:
COMPLETED
Developing an Objective Measure of Experienced Pain
Lead Sponsor:
University of Zurich
Collaborating Sponsors:
Balgrist University Hospital
Conditions:
Pain, Acute
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Pain is a public health challenge around the world. However, there is no single standardized measure of pain, to the point that the estimated prevalence of chronic pain in adults ranges between 2% and...
Detailed Description
The aim of this study is to establish and validate the proposed method of measuring pain using different pain stimuli. The investigators correlate these measurements with physiological data such as sk...
Eligibility Criteria
Inclusion
- age 18-60 years.
- ability and willingness to participate in the study
- declaration of consent
- good English language skills (to ensure understanding of all instructions and the declaration of consent).
Exclusion
- inability to give the declaration of consent (e.g. due to linguistic difficulties understanding the study information)
- any neurological disorders
- reduced general health / chronic diseases (e.g. autoimmune disease, severe cardiovascular diseases, insulin-dependent diabetes, severe depression); chronic pain disorders
- pregnancy
- in the week before the experimental session self-reported intake of drugs which could influence pain perception (e.g. cannabis and ADHD medications).
Key Trial Info
Start Date :
June 6 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 26 2022
Estimated Enrollment :
330 Patients enrolled
Trial Details
Trial ID
NCT05415423
Start Date
June 6 2022
End Date
September 26 2022
Last Update
October 12 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SNS Laboratory
Zurich, CH, Switzerland, 8091